drugset / Trial / NCT04366739

Repurposing of Chlorpromazine in Covid-19 Treatment

NCT04366739

RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the effects of the addition of chlorpromazine to the standard therapeutic protocol in COVID-19 patients hospitalized for respiratory symptom management (score 3-5 WHO Ordinal Scale for Clinical Improvement).

Timeline

Start
2020-04-29
Primary completion
2020-08-30
Completion
2020-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorpromazine Small molecule Oral

Indications